Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_assertion type Assertion NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_head.
- NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_assertion description "[CML is characterized by the chromosomal translocation t(9;22) (q34;q11) resulting in the chimeric bcr-abl oncogene that encodes P210 fusion proteins with novel amino acid sequences in the breakpoint region.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_provenance.
- NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_assertion evidence source_evidence_literature NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_provenance.
- NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_assertion SIO_000772 10803518 NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_provenance.
- NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_assertion wasDerivedFrom befree-2016 NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_provenance.
- NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_assertion wasGeneratedBy ECO_0000203 NP283300.RA2QfCf14G6VWTPyFM7gUtuMhnDpiNLLhhr-bewTQ6Tk4130_provenance.